MedTrace Logo

Gentamicin in Cardiac Surgery

NCT06454643 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2024-06-12

No results posted yet for this study

Summary

Surgical site infection (SSI) is a serious postoperative complication after cardiac surgery that have a negative impact on a patient's health and survival. This study aims to investigate the effectiveness of administering gentamicin in reducing the incidence of SSI with monitoring to the effective therapeutic level.

Conditions

  • Cardiac Infection

Interventions

DRUG

Flucloxacillin and gentamicin

This intervention aimed to investigate the effectiveness of administering gentamicin in reducing the incidence of SSI.

DRUG

Flucloxacillin and ceftriaxone

Control group

Sponsors & Collaborators

  • Al-Rasheed University College

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-01
Primary Completion
2021-01-01
Completion
2021-01-01

Countries

  • Iraq

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06454643 on ClinicalTrials.gov